1. Scrip
  2. >>Business
  3. >>Deals

Verge Builds Out Big Pharma AI Partnerships With AstraZeneca Deal

 
• By Alaric DeArment

Deal Snapshot: Two years into a three-year partnership with Lilly, Verge announced another deal, with AstraZeneca’s Alexion, just months after acquiring bragging rights with early clinical data for an AI-discovered product candidate.

AstraZeneca's Alexion and Verge formed a deal to use AI for drug discovery • Source: Shutterstock

Who: Verge Genomics and Alexion, AstraZeneca Rare Disease

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business